ArticlePediatric cardiology2026
Three-Dimensional Transthoracic Echocardiography as a Tool for Patient Selection for Percutaneous Atrial Septal Defect Closure.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Planning for percutaneous closure of large atrial septal defects presents a challenge for pediatric cardiologists. Transcatheter repair is preferred to open heart surgery however in borderline cases, it may be difficult to assess whether the tissue rims around the atrial septal defect are sufficient for closure in the cath lab. In these cases, three-dimensional echocardiography in the outpatient clinic may assist decision making. All patients referred for atrial septal defect closure at our center, specializing in minimally-invasive surgery, over a three-year period were reviewed. At the start of the study period three-dimensional transthoracic echocardiography was introduced to the outpatient clinic work-up for patients whose two-dimensional echo imaging was insufficient for direct referral to surgical or percutaneous closure. Overall, 36 patients were included in the study. Following two-dimensional imaging 15 patients were referred for surgical closure and 8 patients were referred for percutaneous closure. After three-dimensional echocardiography 12 of 13 patients (age 4-44, median 8 years) were deemed suitable for percutaneous closure. 11 of these patients (weight 15.5-59.8, median 33 kg) underwent successful percutaneous device closure (device size 14-30 mm, median 24 mm). In four patients previously assessed at another tertiary center, surgical repair was recommended. In these, and other borderline cases, adequate rims for transcatheter closure were visualized clearly on three-dimensional echocardiogram. Two patients underwent surgical repair, one at the recommendation of the team, and one at the request of the parents. Three-dimensional transthoracic echocardiography is a useful decision making aid in percutaneous closure of large atrial septal defects. This may be especially useful to less experienced or more conservative interventionalists.
Indexed as
Identifiers
42730768What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.